Exact Mass: 305.97737399999994
Exact Mass Matches: 305.97737399999994
Found 173 metabolites which its exact mass value is equals to given mass value 305.97737399999994,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Uridine 2',3'-cyclic phosphate
C9H11N2O8P (306.02530160000003)
Uridine 2,3-cyclic phosphate is a cyclic nucleotide. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. Cyclic phosphates are commonly found at the 3 end of mRNAs and other small RNAs. Uridine 2,3-cyclic phosphate is a substrate for the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses it to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1. [HMDB] Uridine 2,3-cyclic phosphate is a cyclic nucleotide. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. Cyclic phosphates are commonly found at the 3 end of mRNAs and other small RNAs. Uridine 2,3-cyclic phosphate is a substrate for the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses it to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1.
2,2-Dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrosophenyl)ethyl]acetamide
C11H12Cl2N2O4 (306.01740920000003)
(-)-Mintlactone
(-)-mintlactone is a member of the class of compounds known as benzenesulfonyl compounds. Benzenesulfonyl compounds are aromatic compounds containing a benzenesulfonyl group, which consists of a monocyclic benzene moiety that carries a sulfonyl group (-)-mintlactone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (-)-mintlactone can be found in peppermint, which makes (-)-mintlactone a potential biomarker for the consumption of this food product.
uracil 5-beta-D-ribofuranosyl-2,3-cyclic monophosphate
C9H11N2O8P (306.02530160000003)
ascidiathiazone B
C12H6N2O6S (305.99465760000004)
An organic heterotricyclic compound, that is 5,10-dioxo-5,10-dihydro-1H-[1,4]thiazino[3,2-g]quinoline 4,4-dioxide substituted at position 7 by a carboxy group. It is an anti-inflmmatory alkaloid obtained from Aplidium.
3,5-cUMP|3,5-cyclic UMP|CUMP|cyclic uridine 3,5-monophosphate|Cyclic-3,5-UMP|O3,O5-hydroxyphosphoryl-uridine|uridine 3,5-cyclic monophosphate
C9H11N2O8P (306.02530160000003)
Broxuridine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000963 - Antimetabolites D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.233 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.226 5-BrdU (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA. 5-BrdU is commonly used in the detection of proliferating cells.
4-(4-CHLORO-3-NITRO-BENZENESULFONYL)-MORPHOLINE
C10H11ClN2O5S (306.00771860000003)
4,4,5,5-tetramethyl-2-(2,4,6-trichlorophenyl)-1,3,2-dioxaborolane
C12H14BCl3O2 (306.01523840000004)
3,5-Bis(trifluoromethyl)phenyldimethylchlorosilane
C10H9ClF6Si (306.00662159999996)
2-(3,5-DICHLORO-2-HYDROXYPHENYL)-4-QUINAZOLINE
C14H8Cl2N2O2 (305.99628079999997)
4-[3-(2,4-Dichlorophenyl)isoxazol-5-yl]pyrimidin-2-amine
C13H8Cl2N4O (306.00751379999997)
methyl 4-bromo-2-methyl-5-methylsulfonylbenzoate
C10H11BrO4S (305.95613860000003)
Rimoprogin
C254 - Anti-Infective Agent > C514 - Antifungal Agent
benzyl N-(6-bromo-3-pyridyl)carbamate
C13H11BrN2O2 (306.00038459999996)
tert-butyl N-(4-bromo-5-formyl-1,3-thiazol-2-yl)carbamate
1-bromo-4-(diethoxyphosphorylmethyl)benzene
C11H16BrO3P (306.00203760000005)
6-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)NAPHTHALEN-2-OL
3-(4-BROMOPHENYL)-5-(THIOPHEN-2-YL)-1,2,4-OXADIAZOLE
2-(4-CHLOROPHENYL)-4,4-BIS(METHYLTHIO)-1,3-BUTADIEN-1,1-DICARBONITRILE
Benzyl (5-bromopyridin-3-yl)carbamate
C13H11BrN2O2 (306.00038459999996)
3-iodoadamantane-1-carboxylic acid
C11H15IO2 (306.01167599999997)
Ethyl 2-(6-Nitro-2,3-dichlorobenzyl)glycine
C11H12Cl2N2O4 (306.01740920000003)
Carbonic acid ammonium zirconium salt
C3H8N2O9Zr (305.92768780000006)
Sodium 5-oxo-1-(4-sulfophenyl)-4H-pyrazole-3-carboxylate
C10H7N2NaO6S (305.99225220000005)
Glycine,N-[(2,3-dichloro-6-nitrophenyl)methyl]-, ethyl ester, hydrochloride (1:1)
C11H12Cl2N2O4 (306.01740920000003)
3,4,5-Trichlorophenylboronic acid, pinacol ester
C12H14BCl3O2 (306.01523840000004)
2-BROMO-5-(4-(TRIFLUOROMETHYL)PHENYL)THIOPHENE
C11H6BrF3S (305.93256520000006)
2-(2-chloro-6-fluorobenzyl)-4,5-dichloropyridazine-3-(2h)-one
4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline
1,4-Diamino-2,3-dichloro-9,10-anthraquinone
C14H8Cl2N2O2 (305.99628079999997)
(5-bromo-2-propanoylphenyl) methanesulfonate
C10H11BrO4S (305.95613860000003)
tert-Butyl (2-bromo-6-chloropyridin-3-yl)carbamate
Thiazolo[5,4-g]quinoline-7-carboxylic acid,5-ethyl-2,3,5,8-tetrahydro-8-oxo-2-thioxo-
3-(2-METHOXY BENZYLOXY)-1-IODO PROPANE
C11H15IO2 (306.01167599999997)
N-(5-bromo-2-methoxypyridin-3-yl)cyclopropanesulfonamide
ACETIC ACID ACETOXY-(4-CHLORO SULFONYL PHENYL)METHYL ESTER
Benzyl (5-bromopyridin-2-yl)carbamate
C13H11BrN2O2 (306.00038459999996)
3-(5,6-dichloro-1-benzofuran-2-yl)benzoic acid
C15H8Cl2O3 (305.98504779999996)
2-amino-3-(2-Methoxybenzoyl)-5-bromopyridine
C13H11BrN2O2 (306.00038459999996)
Cyclohexadienyliumiron(0) tricarbonyl tetrafluoroborate
C9H7BF4FeO3 (305.97737399999994)
methyl 2-(trimethylstannyl)thiophene-3-carboxylate
Phenylphosphinic acid magnesium salt
C12H12MgO4P2 (306.00613119999997)
TERT-BUTYL (5-BROMO-2-CHLOROPYRIDIN-3-YL)CARBAMATE
3-(3-Bromo-4-methoxyphenyl)benzoic acid, 2-Bromo-4-(3-carboxyphenyl)anisole, 3-Bromo-3-carboxy-4-methoxybiphenyl
4-BROMO-3-(4-FLUOROPHENYL)PROPIOPHENONE
C15H12BrFO (306.00554939999995)
5-[2-(METHYLTHIO)PYRIMIDIN-4-YL]THIOPHENE-2-SULFONYL CHLORIDE
(5-BROMO-2-HYDROXY-4-METHOXYPHENYL)(PHENYL)METHANONE
2-(3-Bromophenyl)-5-(thiophen-2-yl)-1,3,4-oxadiazole
3-(2,4-dichlorophenyl)-7-hydroxy-4H-chromen-4-one
C15H8Cl2O3 (305.98504779999996)
2-[(2-bromophenyl)methoxy]benzoic Acid
ML-097 (CID-2160985) is a pan Ras-related GTPases activator that can activate Rac1, cell division cycle 42, Ras, and Rab7[1].
5-chloro-N-(1,3-dioxo-5-isoindolyl)-2-thiophenecarboxamide
Technetium TC-99M medronate
CH6O8P2Tc (305.95379360000004)
V - Various > V09 - Diagnostic radiopharmaceuticals > V09B - Skeleton > V09BA - Technetium (99mtc) compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Deoxyuridine-phosphate
C9H11N2O8P-2 (306.02530160000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-(3-chloro-4-fluorophenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine
3-chloro-4-fluoro-N-(3-pyridinyl)-1-benzothiophene-2-carboxamide
2,3-cyclic ump
C9H11N2O8P (306.02530160000003)
A 2,3-cyclic pyrimidine nucleotide in which uridine is the parent nucleoside.
dUMP(2-)
C9H11N2O8P (306.02530160000003)
A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-deoxyuridine 5-monophosphate (dUMP); major species at pH 7.3.
3,5-cyclic UMP
C9H11N2O8P (306.02530160000003)
A 3,5-cyclic pyrimidine nucleotide having uridine as the nucleobase.
D-ribulose 1,5-bisphosphate(4-)
Tetraanion of D-ribulose 1,5-bisphosphate arising from deprotonation of all four phosphate OH groups; major species at pH 7.3.
2′-Bromo-2′-deoxyuridine
2′-Bromo-2′-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
1-({2,6-dihydroxy-2-oxo-tetrahydro-2λ⁵-furo[3,4-d][1,3,2]dioxaphosphol-4-yl}methyl)-4-hydroxypyrimidin-2-one
C9H11N2O8P (306.02530160000003)
4-(3-bromopropa-1,2-dien-1-yl)-12-ethyl-3,7-dioxatricyclo[6.4.0.0²,⁶]dodeca-1(8),9,11-triene
1-[(4ar,6r,7r,7as)-2,7-dihydroxy-2-oxo-tetrahydro-4h-2λ⁵-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-4-hydroxypyrimidin-2-one
C9H11N2O8P (306.02530160000003)
2,4-dichloro-6-(5-chloro-3-nitro-1h-pyrrol-2-yl)phenol
C10H5Cl3N2O3 (305.93657500000006)